Blauvelt, A., Stein Gold, L., Gooderham, M., Strober, B., Pinter, A., Carrascosa, J.-M., Gisondi, P., Bleier, J., Madden, C., Deherder, D., Gomez, N. N., & Warren, R. B. (2022). Bimekizumab efficacy and safety through two years in patients with moderate psoriasis: Analysis of pooled data from five phase 3/3b clinical trials. SKIN The Journal of Cutaneous Medicine, 6(6), s67.